RBOT vicarioussurgical.com: Rasio utang marang kapitalisasi buku

Simbol resmi perusahaan Vicarious Surgical Corp (RBOT)

Environmental risks are minimized through energy-efficient robots that reduce the volume of medical waste. The ratio of financial debt to book capitalization confirms the stability of the structure, where the indicator is maintained at 0.93. Stability is bolstered by unique human-like motor systems for single-incision operations, while protection against macroeconomic crises is ensured by the constant demand for high-tech medical care for Vicarious Surgical Inc. (RBOT).

Vicarious Surgical Inc - Utang-utang marang kapitalisasi buku RBOT (periode 04.07.2022 - 07.03.2026)
Sampel barang Vicarious Surgical Inc

This indicator determines the proportion of borrowed funds within the overall equity structure of the company. For Vicarious Surgical Inc. (RBOT), which is currently in the clinical trial stage, this parameter reflects the balance between external financing and financial autonomy. By analyzing the ratio of total debt to book value of equity, an investor can assess the business's resilience to rising interest rates. A reduction in leverage confirms a conservative approach to borrowing, which is critically important when preparing infrastructure for commercial launch.

Perusahaan pesaing

Utang-utang marang kapitalisasi buku DXCM (DexCom, Inc.)|penumbrainc.com (PEN) - Utang-utang marang nilai buku|NOVT - Rasio utang marang kapitalisasi buku|Rasio utang marang aset resik HAE (Haemonetics Corp)|INSP: Utang-utang marang kapitalisasi buku|Procept (PRCT) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CONMED Corporation|pulsebiosciences.com - Rasio utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku INMD|PMI - Utang-utang marang nilai buku|Surmodics Corp - Utang marang nilai buku|Utang-utang marang kapitalisasi buku Senseonics SENS|NPCE: Utang marang nilai buku|Tactile Systems Technology - Utang marang modal buku|SNWV: Utang-utang marang kapitalisasi buku|OM - Utang-utang marang aset resik|ELMD (SmartVest) - Utang-utang marang kapitalisasi buku|Utang marang nilai buku LENSAR Inc (LNSR)|Utang marang nilai buku RCEL (AVITA Medical, Inc.)|PROF (profoundmedical.com) - Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku Baird Medical BDMD|EDAP - Utang marang nilai buku|Bovie Medical - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku IceCure Medical Ltd|LUNG: Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku TELA|CTSO (CytoSorbents Corp) - Utang-utang marang kapitalisasi buku|Sensus Healthcare Inc (SRTS) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku ZYXI|Utang marang nilai buku electrocore.com ECOR|Utang-utang marang kapitalisasi buku IINN (Inspira Technologies)|Utang-utang marang kapitalisasi buku seastarmedical.com ICU|IRIX - Rasio utang marang kapitalisasi buku|INBS: Rasio utang marang kapitalisasi buku|XAIR (beyondair.net) - Utang marang nilai buku|Profusa, Inc - Rasio utang marang aset resik|SSKN (STRATA Skin Sciences Inc.) - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku glucotrack.com GCTK|Rasio utang marang kapitalisasi buku NanoVibronix (NAOV)|Venus Concept Inc (VERO) - Utang marang aset resik|CHF Solutions - Utang marang nilai buku|Utang-utang marang kapitalisasi buku Aethlon Medical Corp AEMD|TransEnterix - Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik avinger.com AVGR|Biosig Technologies (BSGM) - Rasio utang marang kapitalisasi buku|Rasio utang-utang marang kapitalisasi buku CUTR (Cutera Inc.)|Rasio utang marang kapitalisasi buku Know Labs Corp|Utang marang nilai buku Inari Medical Corp (NARI)|Utang-utang marang kapitalisasi buku NVRO|RSLS - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Silk Road Medical SILK